CRIS Current Research Information System

GAMBERI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 839
AS - Asia 820
EU - Europa 518
AF - Africa 55
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 46
OC - Oceania 7
Totale 2.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 828
VN - Vietnam 277
SG - Singapore 189
CN - Cina 155
IT - Italia 155
GB - Regno Unito 82
HK - Hong Kong 55
DE - Germania 53
SE - Svezia 53
IN - India 43
NL - Olanda 32
BD - Bangladesh 30
BR - Brasile 30
FI - Finlandia 27
FR - Francia 26
RU - Federazione Russa 22
IE - Irlanda 18
CI - Costa d'Avorio 16
SC - Seychelles 16
KR - Corea 15
ZA - Sudafrica 12
CA - Canada 9
EE - Estonia 8
AU - Australia 7
JO - Giordania 7
TG - Togo 7
UA - Ucraina 7
AR - Argentina 6
BG - Bulgaria 6
ID - Indonesia 6
JP - Giappone 6
CL - Cile 4
ES - Italia 4
LT - Lituania 4
TH - Thailandia 4
BE - Belgio 3
EC - Ecuador 3
IL - Israele 3
IQ - Iraq 3
IR - Iran 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
AT - Austria 2
CO - Colombia 2
KE - Kenya 2
PL - Polonia 2
RO - Romania 2
SI - Slovenia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.287
Salva come PNG Salva come JPEG
Città #
Singapore 130
Ashburn 111
Fairfield 70
Southend 69
Chandler 60
Hong Kong 54
Dong Ket 52
Hanoi 51
San Jose 45
Woodbridge 34
Ho Chi Minh City 32
Houston 30
Santa Clara 28
Bologna 27
Helsinki 26
Seattle 26
Hefei 23
Cambridge 22
Beijing 19
Los Angeles 19
Wilmington 19
Dublin 18
Council Bluffs 17
Abidjan 16
Princeton 16
Boardman 14
Milan 14
Ann Arbor 13
Seoul 13
Dallas 11
Lauterbourg 10
Redmond 10
Da Nang 9
Hyderabad 8
New York 8
São Paulo 8
Amman 7
Berlin 7
Florence 7
Lomé 7
Redondo Beach 7
Rome 7
Can Tho 6
Frankfurt am Main 6
Haiphong 6
Melbourne 6
Munich 6
Pune 6
Salsomaggiore Terme 6
San Diego 6
Shanghai 6
Sofia 6
Westminster 6
Bremen 5
Johannesburg 5
Padova 5
Turin 5
Brooklyn 4
Buffalo 4
Guangzhou 4
London 4
Mumbai 4
Saint Petersburg 4
Tokyo 4
Zhengzhou 4
Ân Thi 4
Atlanta 3
Baghdad 3
Brussels 3
Bắc Giang 3
Cesano Maderno 3
Charlotte 3
Falls Church 3
Hải Dương 3
Jiaxing 3
Leawood 3
Modena 3
Montreal 3
Nanchang 3
Nanjing 3
Ninh Bình 3
Paris 3
Phoenix 3
Porto Recanati 3
Pozzo 3
Redwood City 3
Reggio Calabria 3
Reggio Emilia 3
Santiago 3
Sunnyvale 3
Tianjin 3
Tân Tiến 3
Udine 3
Alessandria 2
Amsterdam 2
Bari 2
Bengaluru 2
Biên Hòa 2
Breda 2
Brescia 2
Totale 1.391
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 363
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 242
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe) 209
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 206
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 205
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma 204
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe) 194
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 155
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 137
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis 137
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 114
Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy 84
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials 83
Totale 2.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022175 0 0 17 20 20 6 4 12 2 16 46 32
2022/2023242 21 37 7 39 17 17 8 13 51 4 17 11
2023/2024101 15 16 2 4 7 24 5 12 2 1 11 2
2024/2025348 24 31 31 31 38 16 27 16 7 39 27 61
2025/2026896 105 71 55 44 90 48 83 21 203 74 58 44
2026/202775 29 30 16 0 0 0 0 0 0 0 0 0
Totale 2.333